Brokerages Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) PT at $27.33

Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) have received an average rating of “Moderate Buy” from the seven analysts that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $27.3333.

Several brokerages have recently weighed in on KMTS. Weiss Ratings reissued a “sell (d)” rating on shares of Kestra Medical Technologies in a research report on Wednesday, October 8th. Wells Fargo & Company decreased their target price on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an “overweight” rating on the stock in a research report on Thursday, July 17th. Finally, Wall Street Zen cut shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a research report on Sunday, September 28th.

Kestra Medical Technologies Trading Down 1.7%

Shares of KMTS stock opened at $26.40 on Friday. The company’s 50-day moving average price is $21.00 and its 200-day moving average price is $20.15. The company has a debt-to-equity ratio of 0.23, a current ratio of 6.84 and a quick ratio of 6.84. Kestra Medical Technologies has a twelve month low of $13.25 and a twelve month high of $27.71.

Kestra Medical Technologies (NASDAQ:KMTS) last announced its quarterly earnings results on Thursday, September 11th. The company reported ($0.46) earnings per share for the quarter, beating the consensus estimate of ($0.66) by $0.20. The firm had revenue of $19.37 million for the quarter, compared to analyst estimates of $17.68 million. Kestra Medical Technologies has set its FY 2026 guidance at EPS.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Quarry LP acquired a new position in Kestra Medical Technologies in the first quarter valued at about $33,000. Police & Firemen s Retirement System of New Jersey purchased a new stake in Kestra Medical Technologies during the second quarter worth about $54,000. Russell Investments Group Ltd. increased its stake in Kestra Medical Technologies by 26.5% during the second quarter. Russell Investments Group Ltd. now owns 23,202 shares of the company’s stock worth $385,000 after purchasing an additional 4,859 shares during the period. New York State Common Retirement Fund purchased a new stake in Kestra Medical Technologies during the second quarter worth about $93,000. Finally, Virtu Financial LLC purchased a new stake in Kestra Medical Technologies during the first quarter worth about $210,000.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.